Homology Medicines (FIXX) PT Lowered to $22 at Oppenheimer

October 13, 2021 5:45 AM EDT Send to a Friend
Oppenheimer analyst Matthew Biegler lowered the price target on Homology Medicines (NASDAQ: FIXX) to $22.00 (from $24.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login